ClinConnect ClinConnect Logo
Search / Trial NCT07070791

Combined Upper Extremity Resistance and Aerobic Exercise Training in Patients With Breast Cancer

Launched by HACETTEPE UNIVERSITY · Jul 9, 2025

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Breast Cancer Upper Extremity Resistance Exercise Training Aerobic Exercise Training

ClinConnect Summary

This clinical trial is studying how a special exercise program might help women who have had breast cancer improve the strength and function of their arms. The program combines two types of exercise: resistance training using elastic bands, which gently work the muscles, and aerobic exercise, which helps improve overall fitness. Researchers want to see if this combination can reduce common problems breast cancer survivors face, like arm weakness, swelling (called lymphedema), muscle loss, and general tiredness, while also improving quality of life.

Women between 18 and 80 years old who had breast cancer surgery at least 15 months ago and are not currently active in regular exercise might be eligible to join. Participants should be able to understand and follow instructions and not have other health issues that could affect their arms or ability to exercise safely. If selected, they will take part in guided exercise sessions focused on improving arm strength and fitness, which could help them feel stronger and more capable in daily activities. This study is still looking for volunteers, and it hopes to find better ways to support breast cancer survivors in regaining arm function and overall well-being.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • To be between 18-80 years old,
  • Volunteering to participate in the research,
  • At least 15 months after breast cancer surgery,
  • No problems in reading and/or understanding the scales and being able to co-operate with the tests.
  • Physically inactive (60 minutes of structured exercise per week \<).
  • Exclusion Criteria:
  • Presence of active infection,
  • Presence of bilateral breast cancer,
  • History of surgical, neurological or orthopaedic problems that may affect upper extremity functionality other than breast cancer surgery,
  • Having a neurological disease or other clinical diagnosis that may affect cognitive status,
  • Musculoskeletal and neurological disease that may affect exercise performance, symptomatic heart disease, previous lung surgery and malignant disease.
  • Presence of unstable hypertension or diabetes mellitus.

About Hacettepe University

Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.

Locations

Ankara, State, Turkey

Patients applied

0 patients applied

Trial Officials

Melda Saglam, PhD

Study Chair

Hacettepe University, Ankara, Turkey

Ebru Calik Kutukcu, PhD

Principal Investigator

Hacettepe University, Ankara, Turkey

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported